Amgen Inc.
COMPOSITIONS AND METHODS FOR TREATING LIVER CANCER

Last updated:

Abstract:

Methods and compositions for treating primary hepatic cancers and/or secondary hepatic cancers using a combination of talimogene laherparepvec and pembrolizumab, a pembrolizumab variant or an antigen-binding fragment thereof are provided.

Status:
Application
Type:

Utility

Filling date:

26 Oct 2018

Issue date:

12 Nov 2020